Prediction of perioperative mortality in patients with advanced liver disease and abdominal surgery by the use of different scoring systems and tests;Prädiktion der perioperativen mortalität bei patienten mit fortgeschrittener lebererkrankung und abdominalchirurgischen eingriffen anhand unterschiedlicher score- und testsysteme

Zeitschrift fur Gastroenterologie

Volumn 46, Issue 11, 2008, Pages 1283-1289

  Hofmann, Wolf Peter ^a,c,d   Radle J ^b   Moench, C ^a,c   Bechstein, W ^a,c   Zeuzem, S ^a,c  

^a GOETHE UNIVERSITY   (Germany)

^b Klinik fur Innere Medizin II   (Germany)

^c Interdisziplinäres Leberzentrum Frankfurt ^*

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Colorectal carcinoma; Intestine; Liver

Indexed keywords

DEETHYLLIDOCAINE; INDOCYANINE GREEN;

ABDOMINAL SURGERY; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FUNCTION; MORTALITY; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; REVIEW; SCORING SYSTEM;

ABDOMEN; HOSPITAL MORTALITY; HUMANS; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION TESTS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RISK ASSESSMENT;

EID: 57649121871     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1027624     Document Type: Review

References (48)

1. Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg 1964; 1: 1-85
2. Pugh RN, Murray-Lyon IM, Dawson JL et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-649
3. Garrison RN, Cryer HM, Howard DA et al. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg 1984; 199: 648-655
4. Friedman LS. The risk of surgery in patients with liver disease. Hepatology 1999; 29: 1617-1623
5. Mansour A, Watson W, Shayani V et al. Abdominal operations in patients with cirrhosis: still a major surgical challenge. Surgery 1997; 122: 730-735; discussion 735-736
6. del Olma JA, Flor-Lorente B, Flor-Civera B et al. Risk factors for nonhepatic surgery in patients with cirrhosis. World J Surg 2003; 27: 647-652
7. Angermayr B, Cejna M, Kamel F et al. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 2003; 52: 879-885
8. Schepke M, Roth F, Fimmers R et al. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting. Am J Gastroenterol 2003; 98: 1167-1174
9. Salerno F, Merli M, Cazzaniga M et al. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol 2002; 36: 494-500
10. Kamath PS, Wiesner RH, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470
11. Botta F, Giannini E, Romagnoli P et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut 2003; 52: 134-139
12. Freeman Jr R, Wiesner RH, Harper A et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002; 8: 851-858
13. Sakka SG. Assessing liver function. Curr Opin Crit Care 2007; 13: 207-214
14. Teh S, Nagorney D, Stevens S et al. Risk Factors for Mortality after Surgery in Patients With Cirrhosis. Gastroenterology 2007; 132: 1261-1269
15. Dimick JB, Cowan Jr JA, Knol JA et al. Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a nationally representative database. Arch Surg 2003; 138: 185-191
16. Rädle J, Rau B, Kleinschmidt S et al. Operative Risk in Patients with Liver and Gastrointestinal Diseases. Dtsch Arztebl 2007; 104: A1914-A1921
17. Jarnagin WR, Gonen M, Fong Y et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 2002; 236: 397-406; discussion 406-397
18. Schroeder RA, Marroquin CE, Bute BP et al. Predictive indices of morbidity and mortality after liver resection. Ann Surg 2006; 243: 373-379
19. Ercolani G, Cucchetti A, Cescon M et al. Predictive indices of morbidity and mortality after liver resection. Ann Surg 2006; 244: 635-637; author reply 637
20. Farnsworth N, Fagan SP, Berger DH et al. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients. Am J Surg 2004; 188: 580-583
21. Befeler AS, Palmer DE, Hoffman M et al. The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome. Arch Surg 2005; 140: 650-654; discussion 655
22. Northup PG, Wanamaker RC, Lee VD et al. Model for End-Stage Liver Disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis. Ann Surg 2005; 242: 244-251
23. Teh S, Christein J, Donohue J et al. Hepatic Resection of Hepatocellular Carcinoma in Patients with Cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts Perioperative Mortality. J Gastrointest Surg 2005; 9: 1207-1215
24. Cucchetti A, Ercolani G, Cescon M et al. Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease. J Am Coll Surg 2006; 203: 670-676
25. O'Leary J, Friedman L. Predicting Surgical Risk in Patients with Cirrhosis: From Art to Science. Gastroenterology 2007; 132: 1609-1611
26. Mullin EJ, Metcalfe MS, Maddern GJ. How much liver resection is too much? Am J Surg 2005; 190: 87-97
27. Kanzler S, Teufel A, Galle PR. Liver function test to predict hepatic failure after liver resection - expensive and without clinical relevance? Zentralbl Chir 2007; 132: 267-273
28. Bruix J, Castells A, Bosch J et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996; 111: 1018-1022
29. Zorzi D, Laurent A, Pawlik TM et al. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 2007; 94: 274-286
30. Blum H, Farthmann EH. Der Patient mit Hepatopathie. Chirurg 1997; 68: 763-769
31. Keegan MT, Plevak DJ. Preoperative assessment of the patient with liver disease. Am J Gastroenterol 2005; 100: 2116-2127
32. Fujioka H, Kawashita Y, Kamohara Y et al. Utility of technetium-99m-labeled-galactosyl human serum albumin scintigraphy for estimating the hepatic functional reserve. J Clin Gastroenterol 1999; 28: 329-333
33. Kubota K, Makuuchi M, Kusaka K et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 1997; 26: 1176-1181
34. Fan ST, Lai EC, Lo CM et al. Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg 1995; 130: 198-203
35. Lam CM, Fan ST, Lo CM et al. Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test. Br J Surg 1999; 86: 1012-1017
36. Imamura H, Seyama Y, Kokudo N et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 2003; 138: 1198-1206; discussion 1206
37. Lau H, Man K, Fan ST et al. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 1997; 84: 1255-1259
38. Statland BE, Demas T, Danis M. Letter: Caffeine accumulation associated with alcoholic liver disease. N Engl J Med 1976; 295: 110-111
39. Park GJ, Katelaris PH, Jones DB et al. Validity of the 13C-caffeine breath test as a noninvasive, quantitative test of liver function. Hepatology 2003; 38: 1227-1236
40. Redaelli CA, Dufour JF, Wagner M et al. Preoperative galactose elimination capacity predicts complications and survival after hepatic resection. Ann Surg 2002; 235: 77-85
41. Salerno F, Borroni G, Moser P et al. Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. A prospective multicenter Italian study. AISF Group for the Study of Liver Transplantation. Associazione Italiana per lo Studio del Fegato. J Hepatol 1996; 25: 474-480
42. Oellerich M, Armstrong VW. The MEGX test: a tool for the real-time assessment of hepatic function. Ther Drug Monit 2001; 23: 81-92
43. Ercolani G, Grazi GL, Calliva R et al. The lidocaine (MEGX) test as an index of hepatic function: its clinical usefulness in liver surgery. Surgery 2000; 127: 464-471
44. Ravaioli M, Grazi GL, Principe A et al. Operative risk by the lidocaine test (MEGX) in resected patients for HCC on cirrhosis. Hepatogastroenterology 2003; 50: 1552-1555
45. Huang YS, Chiang JH, Wu JC et al. Risk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma: predictive value of the monoethylglycinexylidide test. Am J Gastroenterol 2002; 97: 1223-1227
46. Addario L, Scaglione G, Tritto G et al. Prognostic value of quantitative liver function tests in viral cirrhosis: a prospective study. Eur J Gastroenterol Hepatol 2006; 18: 713-720
47. Merkel C, Bolognesi M, Bellon S et al. Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis. Gut 1992; 33: 836-842
48. Schneider AR, Caspary WF, Stein J. (13)C-breath tests for the assessment of liver function. Z Gastroenterol 2004; 42: 269-275